The CV, ECG Test Results (EG), and Respiratory Test Results (RE) domains are very similar in structure. Note that the examples provided in this section represent uses of timing variables which could apply to any of these domains, regardless of study type or design.
Example
This example shows different cardiovascular endpoints collected for 1 subject, including examples of both collected and derived baseline measurements. These endpoints were measured at a single point in time at 8 hours post-dose (CVELTM = "PT8H"), per the study protocol. Since the time point is not an interval with a planned start and end, CVSTINT and CVENINT are null.
Rows 1-2, 4-5:
Show measurements performed at a specific time. Note that the same test was performed multiple times on the same day for a subject. In this example, CVDTC is part of the natural key of the dataset (CVDTC contains both date and time), distinguishing one record from the next.
Rows 3, 6:
Represent the mean of the 2 previous rows, which make them derived records (CVDRVFL="Y"), and at the same time serve as baseline values (CVBLFL="Y"). CVDTC now contains information about the date (not time).
Row 7:
Shows an example of a measured baseline value. It is not derived (CVDRVFL is null).
cv.xpt
cv.xpt
Row
STUDYID
DOMAIN
USUBJID
CVSEQ
CVTESTCD
CVTEST
CVPOS
CVORRES
CVORRESU
CVSTRESC
CVSTRESN
CVSTRESU
CVMETHOD
CVCSTATE
CVBLFL
CVDRVFL
CVDTC
CVDY
CVNOMDY
CVTPT
CVTPTNUM
CVELTM
CVTPTREF
CVSTINT
CVENINT
1
ABC
CV
ABC-001-001
1
SYSBP
Systolic Blood Pressure
SITTING
154
mmHg
154
154
mmHg
External Cuff
CONSCIOUS
1999-06-19T08:45
1
1
8 hours postdose
1
PT8H
Day 1 Dose
2
ABC
CV
ABC-001-001
2
SYSBP
Systolic Blood Pressure
SITTING
152
mmHg
152
152
mmHg
External Cuff
CONSCIOUS
1999-06-19T09:00
1
1
8 hours postdose
1
PT8H
Day 1 Dose
3
ABC
CV
ABC-001-001
3
SYSBP
Systolic Blood Pressure
SITTING
153
mmHg
153
153
mmHg
External Cuff
CONSCIOUS
Y
Y
1999-06-19
1
1
8 hours postdose
1
PT8H
Day 1 Dose
4
ABC
CV
ABC-001-001
4
DIABP
Diastolic Blood Pressure
SITTING
44
mmHg
44
44
mmHg
External Cuff
CONSCIOUS
1999-06-19T08:45
1
1
8 hours postdose
1
PT8H
Day 1 Dose
5
ABC
CV
ABC-001-001
5
DIABP
Diastolic Blood Pressure
SITTING
48
mmHg
48
48
mmHg
External Cuff
CONSCIOUS
1999-06-19T09:00
1
1
8 hours postdose
1
PT8H
Day 1 Dose
6
ABC
CV
ABC-001-001
6
DIABP
Diastolic Blood Pressure
SITTING
46
mmHg
46
46
mmHg
External Cuff
CONSCIOUS
Y
Y
1999-06-19
1
1
8 hours postdose
1
PT8H
Day 1 Dose
7
ABC
CV
ABC-001-001
7
PULSEPR
Pulse Pressure
SITTING
107
mmHg
72
72
mmHg
External Cuff
CONSCIOUS
Y
1999-06-19
1
1
8 hours postdose
1
PT8H
Day 1 Dose
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
Example
This example shows measurements on 2 animals at 3 time points (baseline, 120 minutes, 240 minutes) relative to the administration of the third dose level of a Latin square design (with CVTPTREF as "Dose 3"). At each time point, several measurements were assessed (arterial diastolic pressure, arterial heart rate, arterial mean blood pressure). Each measurement summarizes data collected for a planned evaluation interval of 60 minutes that ended at time 0 min, 120 min, and 240 min after the dose. Subject 1003 received the third dose level on day 15 of the study and subject 1008 received this dose level on day 1. The method "Intravascular" is used for measurements taken directly from the vasculature.
cv.xpt
cv.xpt
Row
STUDYID
DOMAIN
USUBJID
CVSEQ
CVTESTCD
CVTEST
CVPOS
CVORRES
CVORRESU
CVSTRESC
CVSTRESN
CVSTRESU
CVMETHOD
CVCSTATE
CVBLFL
CVDTC
CVDY
CVNOMDY
CVTPT
CVTPTNUM
CVELTM
CVTPTREF
CVRFTDTC
CVSTINT
CVENINT
1
AA222
CV
1003
1
DIABP
Diastolic Blood Pressure
UNCONSTRAINED
50.94
mmHg
50.94
50.94
mmHg
Intravascular
CONSCIOUS
Y
2006-09-15
15
15
0 min
0
PT0M
Dose 3
2006-09-15T10:30
-PT60M
PT0M
2
AA222
CV
1003
2
DIABP
Diastolic Blood Pressure
UNCONSTRAINED
50.68
mmHg
50.68
50.68
mmHg
Intravascular
CONSCIOUS
2006-09-15
15
15
120 min
120
PT120M
Dose 3
2006-09-15T10:30
PT60M
PT120M
3
AA222
CV
1003
3
DIABP
Diastolic Blood Pressure
UNCONSTRAINED
49.37
mmHg
49.37
49.37
mmHg
Intravascular
CONSCIOUS
2006-09-15
15
15
240 min
240
PT240M
Dose 3
2006-09-15T10:30
PT180M
PT240M
4
AA222
CV
1003
4
HR
Heart Rate
UNCONSTRAINED
139.2
beats/min
139.2
139.2
beats/min
Intravascular
CONSCIOUS
Y
2006-09-15
15
15
0 min
0
PT0M
Dose 3
2006-09-15T10:30
-PT60M
PT0M
5
AA222
CV
1003
5
HR
Heart Rate
UNCONSTRAINED
128.3
beats/min
128.3
128.3
beats/min
Intravascular
CONSCIOUS
2006-09-15
15
15
120 min
120
PT120M
Dose 3
2006-09-15T10:30
PT60M
PT120M
6
AA222
CV
1003
6
HR
Heart Rate
UNCONSTRAINED
118.4
beats/min
118.4
118.4
beats/min
Intravascular
CONSCIOUS
2006-09-15
15
15
240 min
240
PT240M
Dose 3
2006-09-15T10:30
PT180M
PT240M
7
AA222
CV
1003
7
MAP
Mean Arterial Pressure
UNCONSTRAINED
66.96
mmHg
66.96
66.96
mmHg
Intravascular
CONSCIOUS
Y
2006-09-15
15
15
0 min
0
PT0M
Dose 3
2006-09-15T10:30
-PT60M
PT0M
8
AA222
CV
1003
8
MAP
Mean Arterial Pressure
UNCONSTRAINED
66.66
mmHg
66.66
66.66
mmHg
Intravascular
CONSCIOUS
2006-09-15
15
15
120 min
120
PT120M
Dose 3
2006-09-15T10:30
PT60M
PT120M
9
AA222
CV
1003
9
MAP
Mean Arterial Pressure
UNCONSTRAINED
65.99
mmHg
65.99
65.99
mmHg
Intravascular
CONSCIOUS
2006-09-15
15
15
240 min
240
PT240M
Dose 3
2006-09-15T10:30
PT180M
PT240M
10
AA1111
CV
1008
10
DIABP
Diastolic Blood Pressure
UNCONSTRAINED
34.11
mmHg
34.11
34.11
mmHg
Intravascular
CONSCIOUS
Y
2006-09-01
1
1
0 min
0
PT0M
Dose 3
2006-09-01T10:30
-PT60M
PT0M
11
AA1111
CV
1008
11
DIABP
Diastolic Blood Pressure
UNCONSTRAINED
28.63
mmHg
28.63
28.63
mmHg
Intravascular
CONSCIOUS
2006-09-01
1
1
120 min
120
PT120M
Dose 3
2006-09-01T10:30
PT60M
PT120M
12
AA1111
CV
1008
12
DIABP
Diastolic Blood Pressure
UNCONSTRAINED
28.96
mmHg
28.96
28.96
mmHg
Intravascular
CONSCIOUS
2006-09-01
1
1
240 min
240
PT240M
Dose 3
2006-09-01T10:30
PT180M
PT240M
13
AA1111
CV
1008
13
HR
Heart Rate
UNCONSTRAINED
186.1
beats/min
186.1
186.1
beats/min
Intravascular
CONSCIOUS
Y
2006-09-01
1
1
0 min
0
PT0M
Dose 3
2006-09-01T10:30
-PT60M
PT0M
14
AA1111
CV
1008
14
HR
Heart Rate
UNCONSTRAINED
168.3
beats/min
168.3
168.3
beats/min
Intravascular
CONSCIOUS
2006-09-01
1
1
120 min
120
PT120M
Dose 3
2006-09-01T10:30
PT60M
PT120M
15
AA1111
CV
1008
15
HR
Heart Rate
UNCONSTRAINED
150.8
beats/min
150.8
150.8
beats/min
Intravascular
CONSCIOUS
2006-09-01
1
1
240 min
240
PT240M
Dose 3
2006-09-01T10:30
PT180M
PT240M
16
AA1111
CV
1008
16
MAP
Mean Arterial Pressure
UNCONSTRAINED
53.48
mmHg
53.48
53.48
mmHg
Intravascular
CONSCIOUS
Y
2006-09-01
1
1
0 min
0
PT0M
Dose 3
2006-09-01T10:30
-PT60M
PT0M
17
AA1111
CV
1008
17
MAP
Mean Arterial Pressure
UNCONSTRAINED
47.67
mmHg
47.67
47.67
mmHg
Intravascular
CONSCIOUS
2006-09-01
1
1
120 min
120
PT120M
Dose 3
2006-09-01T10:30
PT60M
PT120M
18
AA1111
CV
1008
18
MAP
Mean Arterial Pressure
UNCONSTRAINED
46.48
mmHg
46.48
46.48
mmHg
Intravascular
CONSCIOUS
2006-09-01
1
1
240 min
240
PT240M
Dose 3
2006-09-01T10:30
PT180M
PT240M
$warningHtml
Example
This example shows heart rates for a single animal where the evaluation intervals changed across the study. The applicant chose to label its time points (CVTPT) based on the hours, minutes, and seconds of the planned time away from dose, based on the end of the evaluation interval.
Row 1:
The pre-dose was monitored for a period of 1 hour, summarized into a 1-hour increment.
Rows 2-9:
From the dose to 2 hours post-dose, the data were summarized in 15-minute increments.
Rows 10-13:
From 2 hours post-dose up to 6 hours post-dose, the data were summarized into 1-hour increments.
Rows 14-16:
From 6 hours post-dose up to 12 hours post-dose, the data were summarized into 2-hour increments.